Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GABAergic neurotransmission refers to the system of neural communication mediated by gamma-aminobutyric acid (GABA), the principal inhibitory neurotransmitter in the mammalian central nervous system (CNS). This system involves GABA synthesis, release, receptor binding, and reuptake, playing a crucial role in regulating neuronal excitability and maintaining a balance between excitation and inhibition. Dysregulation of GABAergic neurotransmission is implicated in various neurological and psychiatric disorders, making it a significant target for therapeutic intervention.
Enhancement of GABA receptor activity, modulation of GABA synthesis or degradation, or alteration of GABA transporter function.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GABAergic Neurotransmission.